The Upjohn Company was a pharmaceutical manufacturing firm founded in 1886 in Kalamazoo, Michigan, by Dr. William E. Upjohn, an 1875 graduate of the University of Michigan medical school. The company was originally formed to make friable pills, which were specifically designed to be easily digested. These could be "reduced to a powder under the thumb", a strong marketing argument at the time.

BioXell was founded in 2002 as a spinout of Roche Milano Ricerche, a leading biomedical research institute created ten years earlier that focused on chronic inflammatory disease and autoimmunity. The idea to create BioXell originated with Francesco Sinigaglia, founder and director of the Milan-based research institute, following a scientific career path that took him to the University College in London, the Basel Institute of Immunology and the Hoffmann-La Roche research units in Basel. Dr. Sinigaglia, former CEO, approached Roche with his challenging project and a year later BioXell was spun off, with $22m invested by MPM Capital, Index Ventures and Life Science Partners.

Kaneka Corp. engages in the manufacture and sale of chemicals, synthetic resins, and plastics. It operates through the following segments: Material Solutions, Quality of Life Solutions, Health Care Solutions, Nutrition Solutions and Others. The Material Solutions segment covers biodegradable polymers, materials that support the development of social infrastructure and mobility which includes the weight reduction and fuel efficiency improvement. The Quality of Life Solutions segment handles energy saving needs such as housing and living infrastructure, and development of Internet of things (IoT) and artificial intelligence (AI). The Health Care Solutions segment offers solutions through the fusion of devices and medicines, and develops healthcare business based on biopharmaceuticals and regenerative and cellular medicines. The Nutrition Solutions segment provides materials and supplement solutions to food production support in livestock and fishery industries. The Others segment provides agency services for property and life insurance. The company was founded on September 1, 1949 and is headquartered in Osaka, Japan.

Rhodia Chimie, part of Solvay SA, is a French company located in Aubervilliers that leases intellectual property and patents.

Daewoong Pharmaceutical Co., Ltd (Korean: 대웅제약) is a Seoul, South Korea-based bioengineering company operating as a subsidiary of Daewoong Co., Ltd., a global health care group. Daewoong Pharmaceutical primarily engages in the manufacture of pharmaceutical products in South Korea, including prescription and over-the-counter healthcare products.

Xi'an Duchuang Pharmaceutical Technology Co., Ltd., established on 2017-06-29, Business scope includes general items:Medical Research and Experimental Development;Technical Services,technology development,technical consulting,Technology Exchange,technology transfer,Technology Promotion;Biochemical product technology research and development;Chemical product sales(No licensed chemical products);Manufacturing of Specialty Chemical Products(Free of Hazardous Chemicals);Information Consulting Service(Not including licensing information consulting services);Experimental analysis instrument sales;Instrument sales;Glassware Sales;Machinery sales;Glass fiber and product sales;Smart Instrument Sales;Wholesale of hardware products;Office Supplies Sales;Specialty Chemicals Sales(Free of Hazardous Chemicals).(Except for projects subject to approval by law,Carry out business activities independently in accordance with the law with a business license)licensed items:Technology Import and Export;Import and export;Inspection and testing service.(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments,Specific business projects are subject to approval results)

Shanghai Hequan Drug Research and Development Co., Ltd., established on 2011-04-15, The business scope includes the research and development of pharmaceutical small molecule compounds(lab only),Research and development of drug synthesis process routes,medicine analysis,Engaged in the import and export of goods and technology. [Items subject to approval by law,Business activities can only be carried out after approval by relevant departments]

Pharmaceutical concern

Zhongshan Bailing Biotechnology Co., Ltd. is a private company headquartered in Zhongshan, China. The firm engages in the development, manufacturing and distribution of pharmaceutical products.

Changzhou Jiaerke Pharmaceuticals Group Corp. Ltd. is a Chinese private company. The firm manufactures and supplies hippocampus & blood capsules.

Beijing Union Pharmaceutical Factory is a private company headquartered in China that manufactures pharmaceutical products.

Suzhou Zhengyong Biomedical Co., Ltd., established on 2017-01-16, Business scope includes technology development in the field of biomedicine,technical consulting,technology transfer;research and development,retail:medicine;Sales:Non-hazardous chemical products;Engaged in the import and export business of the above products and technologies.(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments)

Chongqing Shenghuaxi Pharmaceutical Co., Ltd., established on 1999-09-28, The scope of business includes the production of small volume injections,Freeze-dried powder injection,tablet,hard capsule,oral solution,powder injection(Contains cephalosporins),Sterile API,API.(Engage in business according to the approved scope and period of the license)manufacture,Sales of pharmaceutical intermediates;drug research,Development and transfer.(Except for those prohibited by the state,Those that should be approved shall not operate before obtaining the approval)

Nanchangyou Pharmaceutical Technology Co., Ltd., established on 2011-05-19, Business scope includes research and development of pharmaceutical technology;Chemical Products(Rosuvastatin Calcium,Aliskiren,Pregabalin,ezetimibe,Sofosbuvir,Ticagrelor,Canagliflozin,Daclatasvir dihydrochloride,Shakubi,Velpatasvir copovidone,Rivaroxaban,Raw material of celecoxib)Production,Sales;Self-management and agency of various commodity import and export business(Except for goods that the state restricts the company to operate or prohibits import and export).(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments)

Zhejiang NHU Company Ltd. provides solutions for animal and human nutrition, medicine, health, environmental protection, and engineering plastics worldwide. It offers ingredients, vitamins, carotenoids, aroma chemicals, polymers, flavors and fragrances, etc.; and APIs and intermediates covering various areas, such as cardiovascular, anti-aids, anti-cancer, and anti-bacterial.

Readline is a bio-pharmaceutical high-tech company with a multidisciplinary application based on enzyme catalysis technology. It is the world's first company to use directed evolution of enzymes in the large-scale production of API such as peptides, carbohydrate, and nucleic acids on an all-green basis. These APIs are primarily used in medicine, health care products, cosmetics, animal feed, biological pesticides, fertilizers, and other applications.

Gritpharma engaged in the industrialization of new pharmaceutical products, technology transfer, technical assistance, and the creation of new drugs. Complete business skills in areas like clinical research.

Part of Pfizer Inc., Parke-Davis & Co. Ltd. is a British company located in St. Helier that operates pharmaceutical company.

Hangzhou Keyao Pharmaceutical Technology Co., Ltd., established on 2014-05-20, Business scope includes technology development,Technical Services,technical consulting,Achievement transfer:medical technology,Biotechnology,chemical product(Removal of hazardous chemicals and precursor chemicals),Laboratory equipment;wholesale,retail:Laboratory equipment,Office Supplies,Daily necessities,Chemical raw materials and products(Removal of hazardous chemicals and precursor chemicals).